Home > Clinical Resources > Liver > Liver Guidance > NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

NICE Guidance: Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C

Last Updated on 31 Jan 2020

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.